21-46116387-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_001849.4(COL6A2):c.911G>T(p.Gly304Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.911G>T | p.Gly304Val | missense_variant | Exon 8 of 28 | ENST00000300527.9 | NP_001840.3 | |
COL6A2 | NM_058174.3 | c.911G>T | p.Gly304Val | missense_variant | Exon 8 of 28 | NP_478054.2 | ||
COL6A2 | NM_058175.3 | c.911G>T | p.Gly304Val | missense_variant | Exon 8 of 28 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.911G>T | p.Gly304Val | missense_variant | Exon 8 of 28 | 1 | NM_001849.4 | ENSP00000300527.4 | ||
COL6A2 | ENST00000397763.6 | c.911G>T | p.Gly304Val | missense_variant | Exon 8 of 28 | 5 | ENSP00000380870.1 | |||
COL6A2 | ENST00000409416.6 | c.911G>T | p.Gly304Val | missense_variant | Exon 7 of 27 | 5 | ENSP00000387115.1 | |||
COL6A2 | ENST00000485591.1 | n.567G>T | non_coding_transcript_exon_variant | Exon 4 of 7 | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:1
This sequence change replaces glycine with valine at codon 304 of the COL6A2 protein (p.Gly304Val). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and valine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a COL6A2-related disease. In summary, this variant is a rare missense change that resides within the COL6A2 triple helix region. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Glycine residues within the triple helix region are crucial to maintain fibrillar collagens structure and stability (PMID: 7695699, 19344236). In the case of COL6A2, missense substitutions that affect glycine residues within the triplex helix domain have been reported in many patients affected with autosomal dominant collagen VI myopathy (PMID: 24038877). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at